Cancer Research The Future of Cancer Research: Science and Patient Impact  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 56, 1023-1030, March 1, 1996]
© 1996 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Katiyar, S. K.
Right arrow Articles by Mukhtar, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Katiyar, S. K.
Right arrow Articles by Mukhtar, H.

Inhibition of Tumor Promotion in SENCAR Mouse Skin by Ethanol Extract of Zingiber officinale Rhizome1

Santosh K. Katiyar, Rajesh Agarwal and Hasan Mukhtar2

Department of Dermatology, Skin Diseases Research Center, University Hospitals of Cleveland, Case Western Reserve University, Cleveland, Ohio 44106

There is considerable emphasis on identifying potential chemopreventive agents present in food consumed by the human population. Ginger rhizome (Zingiber officinale), known commonly as ginger, is consumed worldwide in cookeries as a spice and a flavoring agent. In prior in vitro studies, it has been shown that the water or organic solvent extract of ginger possesses antioxidative and antiinflammatory properties. In this study, we evaluated whether ethanol extract of ginger (GE) possesses anti-tumor-promoting effects in a mouse skin tumorigenesis model. Because skin tumor promoters induced epidermal ornithine decarboxylase (ODC), cyclooxygenase, and lipoxygenase activities, and edema and hyperplasia are conventionally used markers of skin tumor promotion, first, we assessed the effect of GE on these parameters. Preapplication of GE onto the skin of SENCAR mice resulted in significant inhibition of 12-O-tetradecanoylphorbol-13-acetate (TPA)-caused induction of epidermal ODC, cyclooxygenase, and lipoxygenase activities and ODC mRNA expression in a dose-dependent manner. Preapplication of GE to mouse skin also afforded significant inhibition of TPA-caused epidermal edema (56%) and hyperplasia (44%). In long-term tumor studies, topical application of GE 30 min prior to that of each TPA application to 7,12-dimethylbenz(a)anthracene-initiated SENCAR mice resulted in a highly significant protection against skin tumor incidence and its subsequent multiplicity. The animals pretreated with GE showed substantially lower tumor body burdens compared with non-GE-treated controls. The results of our study, for the first time, provide clear evidence that GE possesses anti-skin tumor-promoting effects, and that the mechanism of such effects may involve inhibition of tumor promoter-caused cellular, biochemical, and molecular changes in mouse skin.

1 This work was supported by USPHS Grant ES-1900, American Institute for Cancer Research Grant 92B35, and Skin Diseases Research Center Core Grant P-30-AR-39750.

2 To whom requests for reprints should be addressed, at Department of Dermatology, University Hospitals of Cleveland, Case Western Reserve University, 2074 Abington Road, Cleveland, OH 44106. Phone: (216) 368-1127; Fax: (216) 368-0212.

Received 9/20/95. Accepted 1/ 2/96.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
S. M. Zick, Z. Djuric, M. T. Ruffin, A. J. Litzinger, D. P. Normolle, S. Alrawi, M. R. Feng, and D. E. Brenner
Pharmacokinetics of 6-Gingerol, 8-Gingerol, 10-Gingerol, and 6-Shogaol and Conjugate Metabolites in Healthy Human Subjects
Cancer Epidemiol. Biomarkers Prev., August 1, 2008; 17(8): 1930 - 1936.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. W Lampe
Spicing up a vegetarian diet: chemopreventive effects of phytochemicals
Am. J. Clinical Nutrition, September 1, 2003; 78(3): 579S - 583.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
C. Dwivedi, X. Guan, W. L. Harmsen, A. L. Voss, D. E. Goetz-Parten, E. M. Koopman, K. M. Johnson, H. B. Valluri, and D. P. Matthees
Chemopreventive Effects of {alpha}-Santalol on Skin Tumor Development in CD-1 and SENCAR Mice
Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 151 - 156.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. Bode, W.-Y. Ma, Y.-J. Surh, and Z. Dong
Inhibition of Epidermal Growth Factor-induced Cell Transformation and Activator Protein 1 Activation by [6]-Gingerol
Cancer Res., February 1, 2001; 61(3): 850 - 853.
[Abstract] [Full Text]


Home page
Arch DermatolHome page
S. K. Katiyar, N. Ahmad, and H. Mukhtar
Green Tea and Skin
Arch Dermatol, August 1, 2000; 136(8): 989 - 994.
[Abstract] [Full Text] [PDF]


Home page
Arch DermatolHome page
G. S. Wood
Green Tea: What's Brewing?
Arch Dermatol, August 1, 2000; 136(8): 1051 - 1051.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1996 by the American Association for Cancer Research.